COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Yaling Hu
Institution
Sinovac Biotech Co.
Address
Beijing
China
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2010
1
2014
2
2015
2
2016
1
2017
1
2018
1
2020
3
2021
6
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Zhao Y
,
Kuang M
,
Li J
,
Zhu L
,
Jia Z
,
Guo X
,
Hu Y
,
Kong J
,
Yin H
,
Wang X
,
You F
. Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4. Cell Res. 2021 Jul; 31(7):825.
PMID:
33907310
.
Citations:
5
Fields:
Cel
Cell Biology
Guan L
,
Yu Y
,
Wu X
,
Nie J
,
Zhang J
,
Wang Z
,
Li N
,
Shi R
,
Zhao H
,
Chen H
,
Luo C
,
Hu Y
,
Wang Y
,
Huang W
,
Xu M
,
Hou J
. The first Chinese national standards for SARS-CoV-2 neutralizing antibody. Vaccine. 2021 06 23; 39(28):3724-3730.
PMID:
34059373
.
Citations:
1
Fields:
All
Allergy and Immunology
Translation:
Humans
Zhao Y
,
Kuang M
,
Li J
,
Zhu L
,
Jia Z
,
Guo X
,
Hu Y
,
Kong J
,
Yin H
,
Wang X
,
You F
. SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 2021 07; 31(7):818-820.
PMID:
33742149
.
Citations:
26
Fields:
Cel
Cell Biology
Translation:
Humans
Cells
Feng X
,
Yin J
,
Zhang J
,
Hu Y
,
Ouyang Y
,
Qiao S
,
Zhao H
,
Zhang T
,
Li X
,
Zhang L
,
Zhang J
,
Jin R
,
Feng Y
,
Su B
. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China. Front Immunol. 2021; 12:614436.
PMID:
33790892
.
Citations:
5
Fields:
All
Allergy and Immunology
Translation:
Humans
Cells
Wu Z
,
Hu Y
,
Xu M
,
Chen Z
,
Yang W
,
Jiang Z
,
Li M
,
Jin H
,
Cui G
,
Chen P
,
Wang L
,
Zhao G
,
Ding Y
,
Zhao Y
,
Yin W
. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 06; 21(6):803-812.
PMID:
33548194
.
Citations:
94
Fields:
Com
Communicable Diseases
Translation:
Humans
PH
Public Health
Shen Y
,
Ba Y
,
Hu Y
,
Wang L
,
Li W
. Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge. Inflamm Res. 2021 Feb; 70(2):241-247.
PMID:
33385239
.
Citations:
1
Fields:
All
Allergy and Immunology
Pat
Pathology
Translation:
Humans
Cells
Wang X
,
Guo X
,
Xin Q
,
Pan Y
,
Hu Y
,
Li J
,
Chu Y
,
Feng Y
,
Wang Q
. Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients. Clin Infect Dis. 2020 12 17; 71(10):2688-2694.
PMID:
32497196
.
Citations:
107
Fields:
Com
Communicable Diseases
Translation:
Humans
Zhang Y
,
Zeng G
,
Pan H
,
Li C
,
Hu Y
,
Chu K
,
Han W
,
Chen Z
,
Tang R
,
Yin W
,
Chen X
,
Hu Y
,
Liu X
,
Jiang C
,
Li J
,
Yang M
,
Song Y
,
Wang X
,
Gao Q
,
Zhu F
. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 02; 21(2):181-192.
PMID:
33217362
.
Citations:
278
Fields:
Com
Communicable Diseases
Translation:
Humans
PH
Public Health
CT
Clinical Trials
Gao Q
,
Bao L
,
Mao H
,
Wang L
,
Xu K
,
Yang M
,
Li Y
,
Zhu L
,
Wang N
,
Lv Z
,
Gao H
,
Ge X
,
Kan B
,
Hu Y
,
Liu J
,
Cai F
,
Jiang D
,
Yin Y
,
Qin C
,
Li J
,
Gong X
,
Lou X
,
Shi W
,
Wu D
,
Zhang H
,
Zhu L
,
Deng W
,
Li Y
,
Lu J
,
Li C
,
Wang X
,
Yin W
,
Zhang Y
,
Qin C
. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 07 03; 369(6499):77-81.
PMID:
32376603
.
Citations:
457
Fields:
Sci
Science
Translation:
Animals
Cells
PH
Public Health
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs